How should fungal sinusitis be managed according to its type (invasive, allergic, or non‑invasive)?

Management of Fungal Sinusitis

Fungal sinusitis management is determined entirely by its classification: non-invasive forms (allergic fungal sinusitis and fungus ball) require complete surgical removal with steroids for allergic variants, while invasive fungal sinusitis demands immediate aggressive surgical debridement combined with systemic antifungals and reversal of immunosuppression. 1

Classification-Based Treatment Algorithm

Non-Invasive Forms

Allergic Fungal Sinusitis (Most Common)

Occurs in immunocompetent, atopic patients with nasal polyps and chronic congestion. 2 Look for:

• Peanut butter-like sinus material on imaging
• Elevated total serum IgE and positive fungal skin tests
• Unilateral disease in children, sometimes with facial deformity
• Common fungi: Bipolaris, Curvularia, Aspergillus, Dreschlera

Treatment requires complete surgical exenteration with mucosal preservation PLUS systemic corticosteroid therapy. 2 The role of postsurgical antifungal therapy remains unproven but may be adjunctive based on anecdotal reports. 2 This is primarily an inflammatory disease, not an invasive infection, so treatment modulates inflammation rather than eradicating fungus. 3

Critical pitfall: Despite aggressive treatment, recurrence rates remain high (16.6% in recent series), requiring close long-term follow-up. 4

Fungus Ball (Mycetoma)

Typically unilateral in maxillary or sphenoid sinuses. 2 Distinguished by:

• Dense concentric layers of hyphae on histology
• NO eosinophilic mucin present (key difference from allergic form)
• Chronic symptoms: nasal obstruction, headache
• Pressure necrosis possible but invasion rare

Surgical removal alone is curative—no antifungals needed. 2, 5 Enlargement of sinus ostomy may prevent recurrence. 5

Invasive Fungal Sinusitis (Life-Threatening)

This fulminant disease occurs in immunocompromised patients: diabetics, neutropenic patients, those on high-dose steroids, transplant recipients, or patients with T-cell immunodeficiencies. 2 Recognize by:

• Fever, headache, epistaxis, mental status changes
• Insensate nasal ulcers
• Necrotic tissue on endoscopy (hallmark sign)—especially middle turbinate, palate, or lateral wall 1
• Unilateral disease on imaging
• Histopathology showing hyphal invasion of mucosa, submucosa, vessels, or bone 1

The three mandatory treatment principles are: 1

1. Start systemic antifungals immediately

   • Voriconazole is first-line for Aspergillus species 1, 5
   • Liposomal amphotericin B for other fungi or voriconazole intolerance 1
   • Improved survival demonstrated with liposomal amphotericin (60% vs lower rates with other agents) 1

2. Perform aggressive surgical debridement of all necrotic tissue (at minimum endoscopic, though open surgery shows 54% survival vs 64% for ESS) 1

3. Reduce immunosuppression when feasible 1

Prognosis remains grave: Overall survival approximately 50-60% despite treatment. 1 Worse outcomes with:

• Hematologic malignancy (hazard ratio 3.7)
• Recent chemotherapy (HR 2.3)
• Bone marrow transplant (HR 2.5)
• Intracranial/cavernous sinus extension (25% survival)
• Neutropenia (29% survival)

Avoid corticosteroids (topical or systemic) as they worsen immunosuppression, unless absolutely necessary for orbital/cerebral edema. 1

Diagnostic Approach by Type

For suspected invasive disease:

• MRI more sensitive (86%) than CT (69%) for detecting invasion 1
• Loss of contrast enhancement indicates tissue necrosis
• Frozen section during surgery confirms invasion 1
• Serum galactomannan and (1,3)-beta-D-glucan: 80% sensitivity/specificity for Aspergillus; when both negative, NPV is 100% 1

For non-invasive disease:

• CT adequate for fungus ball and allergic forms 6
• Histopathology distinguishes allergic (eosinophilic mucin + scattered hyphae) from fungus ball (dense hyphal layers) 2

Key Clinical Pitfalls

1. Unilateral polypoid disease requires biopsy—may be fungal or tumor (inverted papilloma) 2

2. Surgery is mandatory for all fungal sinusitis types—medical therapy alone fails 2

3. Post-operative management is critical for allergic forms—requires intensive local care, appropriate medical therapy, and allergy management to prevent recurrence 2

4. Immunocompetent patients can rarely develop invasive disease after local trauma or with local immunosuppression (e.g., post-surgical steroid packs), though this is extremely uncommon 7